Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Oren Gilad, PhD$21.5M
Market Cap • 26/07/20242019
(há 5 anos)
2019
(5 years ago)
NASDAQ
Listagem
Doylestown
Sede • Pennsylvania9
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
APRESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.